Enteric Nervous System Neurons In Parkinson'S Disease is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The enteric nervous system (ENS) contains millions of neurons that control the gastrointestinal tract. In Parkinson's disease, alpha-synuclein pathology and neurodegeneration extend to the ENS, often preceding motor symptoms by years or decades.
| Property |
Value |
| Cell Type |
Enteric Neurons |
| Location |
Myenteric (Auerbach's) and submucosal (Meissner's) plexuses of the GI tract |
| Neurotransmitters |
Acetylcholine, nitric oxide, VIP, 5-HT |
| Associated Diseases |
Parkinson's Disease, Multiple System Atrophy |
| Model Systems |
Human iPSC-derived enteric neurons, mouse ENS cultures |
Enteric neurons control gut motility, secretion, and blood flow. They operate largely independently of the central nervous system but communicate bidirectionally via the vagus nerve. The myenteric plexus primarily regulates peristalsis, while the submucosal plexus controls secretion and mucosal blood flow.
- Lewy bodies and Lewy neurites containing phosphorylated alpha-synuclein have been observed in enteric neurons of PD patients [1]
- The prion-like spread hypothesis suggests that pathological alpha-synuclein may propagate from the gut to the brain via the vagus nerve [2]
- Studies show alpha-synuclein pathology in the ENS can precede motor symptoms by 10-20 years
- Constipation is one of the most common prodromal symptoms of PD
- Delayed gastric emptying and colonic transit abnormalities are prevalent
- Enteric neuropathy may contribute to malabsorption and nutritional issues
- Rectal biopsy can detect alpha-synuclein pathology in enteric neurons [3]
- Skin biopsy from sympathetic fibers provides similar diagnostic information
- ENS testing may enable early PD diagnosis before motor onset
- Gut-targeted interventions (probiotics, fecal microbiota transplantation) are being explored
- Preventing alpha-synuclein propagation from the ENS may slow disease progression
- Vagus nerve stimulation affects both gut and brain function
- iPSC-derived enteric neurons: Patient-specific models carrying PD mutations (LRRK2, GBA, SNCA)
- Animal models: Mouse models with alpha-synuclein overexpression show ENS pathology
- Organoid systems: Gut-brain axis organoids to study alpha-synuclein transmission
The study of Enteric Nervous System Neurons In Parkinson'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Braak et al., 2003 - Staging of brain pathology in sporadic Parkinson's disease
- Hawkes et al., 2007 - A primal role for the vagus nerve in the pathogenesis of Parkinson's disease
- Lebouvier et al., 2008 - Rectal biopsy and neuropathology in Parkinson's disease